Baker / Tisch Capital (GP), LLC Insider Trading $SGEN Seagen Inc.
Get free email notifications about insider trading for Baker / Tisch Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker / Tisch Capital (GP), LLC. Baker / Tisch Capital (GP), LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX).
Baker / Tisch Capital (GP), LLC in Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker / Tisch Capital (GP), LLC: Director
Holdings: 400,898 shares
Current Value: $24,370,589
Latest Transaction: May 20 2009
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker / Tisch Capital (GP), LLC in Seagen Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, ALTH, IBPI, BCRX, GHDX, INCY, NRGN, SGEN, GEVA, VPHM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 20 2009 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 9.72 | 35,253 | 342,659 | 400,898 | 365.6 K to 400.9 K (+9.64 %) |
| Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 8.06 | 185 | 1,490 | 365,645 | 365.5 K to 365.6 K (+0.05 %) |
| Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 8.08 | 398 | 3,217 | 365,460 | 365.1 K to 365.5 K (+0.11 %) |
| Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 7.93 | 181 | 1,434 | 365,062 | 364.9 K to 365.1 K (+0.05 %) |
| Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 7.98 | 55 | 439 | 364,881 | 364.8 K to 364.9 K (+0.02 %) |
| Feb 11 2008 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 9.06 | 723 | 6,547 | 364,826 | 364.1 K to 364.8 K (+0.20 %) |
| Feb 11 2008 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 8.94 | 6 | 54 | 364,103 | 364.1 K to 364.1 K (0.00 %) |
| Feb 11 2008 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 9.00 | 332 | 2,989 | 364,097 | 363.8 K to 364.1 K (+0.09 %) |
| Feb 11 2008 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 9.00 | 97 | 873 | 363,765 | 363.7 K to 363.8 K (+0.03 %) |
| Jan 23 2008 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 9.03 | 1,915 | 17,288 | 363,668 | 361.8 K to 363.7 K (+0.53 %) |
| Jan 23 2008 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 8.78 | 1,344 | 11,797 | 361,753 | 360.4 K to 361.8 K (+0.37 %) |
| Jan 23 2008 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 9.00 | 39,911 | 359,199 | 360,409 | 320.5 K to 360.4 K (+12.45 %) |
| Jul 11 2007 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | C | 0.00 | 31,650 | 0 | 0 | |
| Jul 11 2007 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | C | 0.00 | 316,500 | 0 | 320,498 | 4 K to 320.5 K (+7,916.46 %) |
| Feb 16 2007 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | C | 0.00 | 8,000 | 0 | 31,650 | |
| Feb 16 2007 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Sell | S | 8.76 | 102,935 | 901,711 | 3,998 | 106.9 K to 4 K (-96.26 %) |
| Feb 16 2007 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | C | 0.00 | 80,000 | 0 | 106,933 | 26.9 K to 106.9 K (+297.03 %) |
Page: 1